CH571480A5 - - Google Patents

Info

Publication number
CH571480A5
CH571480A5 CH857371A CH857371A CH571480A5 CH 571480 A5 CH571480 A5 CH 571480A5 CH 857371 A CH857371 A CH 857371A CH 857371 A CH857371 A CH 857371A CH 571480 A5 CH571480 A5 CH 571480A5
Authority
CH
Switzerland
Application number
CH857371A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CH571480A5 publication Critical patent/CH571480A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195Radicals derived from nitrogen analogues of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CH857371A 1970-06-13 1971-06-11 CH571480A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2029299A DE2029299C3 (de) 1970-06-13 1970-06-13 Neue Aminophenylamidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH571480A5 true CH571480A5 (xx) 1976-01-15

Family

ID=5773921

Family Applications (3)

Application Number Title Priority Date Filing Date
CH532975A CH569703A5 (xx) 1970-06-13 1971-06-11
CH857371A CH571480A5 (xx) 1970-06-13 1971-06-11
CH532875A CH572464A5 (xx) 1970-06-13 1971-06-11

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH532975A CH569703A5 (xx) 1970-06-13 1971-06-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH532875A CH572464A5 (xx) 1970-06-13 1971-06-11

Country Status (23)

Country Link
US (1) US3855292A (xx)
JP (7) JPS5813537B1 (xx)
AT (1) AT312580B (xx)
BE (1) BE768403A (xx)
CA (1) CA930365A (xx)
CH (3) CH569703A5 (xx)
CS (2) CS171700B2 (xx)
DD (1) DD95085A5 (xx)
DE (1) DE2029299C3 (xx)
DK (1) DK129339B (xx)
ES (2) ES392167A1 (xx)
FR (1) FR2100757B1 (xx)
GB (1) GB1325529A (xx)
HU (1) HU162207B (xx)
IE (1) IE35363B1 (xx)
IL (1) IL37025A (xx)
NL (1) NL7108070A (xx)
PH (1) PH9765A (xx)
PL (1) PL77584B1 (xx)
RO (2) RO59026A (xx)
SE (1) SE366301B (xx)
SU (1) SU452092A3 (xx)
ZA (1) ZA713765B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018814A (en) * 1970-06-13 1977-04-19 Bayer Aktiengesellschaft Aromatic amides and carbomates of phenylamidines
US4056631A (en) * 1973-10-23 1977-11-01 Showa Denko K.K. Method of combatting ticks
JPS5069226A (xx) * 1973-10-23 1975-06-10
DE2758005A1 (de) * 1977-12-24 1979-06-28 Bayer Ag Phosphonylureidobenzol-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4360466A (en) * 1981-11-25 1982-11-23 American Cyanamid Company N'-[2,6-Dichloro-4-(substituted-benzylideneamino)phenyl]-N,N-dimethylformamidines
JPH0132822Y2 (xx) * 1984-10-17 1989-10-05
DE3828759A1 (de) * 1988-08-25 1990-03-01 Bayer Ag Neue cyclische amidine und verfahren zu ihrer herstellung
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
JPH04134260U (ja) * 1991-05-24 1992-12-14 藤和機工株式会社 注湯装置
CN100348577C (zh) * 2004-05-12 2007-11-14 中国疾病预防控制中心寄生虫病预防控制所 一种药用化合物及其驱虫用途
DE102007061262A1 (de) * 2007-12-19 2009-06-25 Bayer Animal Health Gmbh Neue Verwendung von Tribendimidin
DE102008030764A1 (de) * 2008-06-28 2009-12-31 Bayer Animal Health Gmbh Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
EP3924298A1 (en) 2019-02-15 2021-12-22 Albemarle Corporation Methods for extracting boron from an organic solution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182053A (en) * 1961-11-20 1965-05-04 Hoffmann La Roche Pyridine formamidines of primary amines
US3189648A (en) * 1962-04-11 1965-06-15 Du Pont Process for preparing n, n-dialkyl-n'-arylamidines
US3121084A (en) * 1962-09-17 1964-02-11 Du Pont Selected n, n, n'-trisubstituted amidines and their preparation by reaction of compounds with-nh2 groups with amide acetals
GB1212454A (en) * 1967-03-04 1970-11-18 Egyt Gyogyszervegyeszeti Gyar N,n'-substituted formamidines

Also Published As

Publication number Publication date
NL7108070A (xx) 1971-12-15
RO59026A (xx) 1975-10-15
CS171699B2 (xx) 1976-10-29
DK129339C (xx) 1975-02-17
FR2100757A1 (xx) 1972-03-24
ES392167A1 (es) 1974-02-01
JPS5813537B1 (xx) 1983-03-14
JPS55143957A (en) 1980-11-10
SE366301B (xx) 1974-04-22
CS171700B2 (xx) 1976-10-29
SU399113A3 (xx) 1973-09-27
DE2029299C3 (de) 1980-08-21
CH569703A5 (xx) 1975-11-28
GB1325529A (en) 1973-08-01
IE35363L (en) 1971-12-13
US3855292A (en) 1974-12-17
SU452092A3 (ru) 1974-11-30
CA930365A (en) 1973-07-17
CH572464A5 (xx) 1976-02-13
DD95085A5 (xx) 1973-01-12
IL37025A (en) 1974-09-10
JPS55143958A (en) 1980-11-10
JPS56123968A (en) 1981-09-29
PH9765A (en) 1976-03-12
BE768403A (fr) 1971-12-13
AT312580B (de) 1974-01-10
IL37025A0 (en) 1971-08-25
ES402622A1 (es) 1975-04-01
HU162207B (xx) 1973-01-29
DK129339B (da) 1974-09-30
ZA713765B (en) 1972-01-26
FR2100757B1 (xx) 1975-01-17
DE2029299A1 (de) 1971-12-30
IE35363B1 (en) 1976-01-21
JPS5715108B2 (xx) 1982-03-29
PL77584B1 (xx) 1975-04-30
JPS57131760A (en) 1982-08-14
DE2029299B2 (de) 1979-10-18
JPS57131761A (en) 1982-08-14
JPS55143956A (en) 1980-11-10
RO59039A (xx) 1976-06-15

Similar Documents

Publication Publication Date Title
AR204384A1 (xx)
DK129339C (xx)
ATA96471A (xx)
AU1146470A (xx)
AU1326870A (xx)
AU1716970A (xx)
AU1336970A (xx)
AU1064870A (xx)
AU1247570A (xx)
AU1086670A (xx)
AU1689770A (xx)
AU1328670A (xx)
ATA672271A (xx)
AU1004470A (xx)
AU1277070A (xx)
AU1189670A (xx)
AU1235770A (xx)
CH564516A5 (xx)
CH574488A5 (xx)
AU1278969A (xx)
AU1095669A (xx)
AU1103769A (xx)
CH567281A5 (xx)
BG16744A3 (xx)
CH562238A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased